{
    "root": "21e18c1c-fabb-44a4-a33a-b02a47967d73",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Metoprolol Succinate",
    "value": "20250430",
    "ingredients": [
        {
            "name": "SODIUM STEARYL FUMARATE",
            "code": "7CV7WJK4UI"
        },
        {
            "name": "ACETYLTRIBUTYL CITRATE",
            "code": "0ZBX0N59RZ"
        },
        {
            "name": "CARNAUBA WAX",
            "code": "R12CBM0EIZ"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4"
        },
        {
            "name": "ETHYLCELLULOSE (10 MPA.S)",
            "code": "3DYK7UYZ62"
        },
        {
            "name": "GLYCERYL DIBEHENATE",
            "code": "R8WTH25YS2"
        },
        {
            "name": "HYDROXYPROPYL CELLULOSE (110000 WAMW)",
            "code": "5Y0974F5PW"
        },
        {
            "name": "HYPROMELLOSE 2910 (6 MPA.S)",
            "code": "0WZ8WG20P6"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U"
        },
        {
            "name": "POLYETHYLENE GLYCOL 6000",
            "code": "30IQX730WE"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        },
        {
            "name": "POLYETHYLENE GLYCOL 400",
            "code": "B697894SGQ"
        },
        {
            "name": "METOPROLOL SUCCINATE",
            "code": "TH25PD4CCB"
        }
    ],
    "indications": "metoprolol succinate beta-adrenergic blocker indicated treatment : • hypertension , lower blood pressure . lowering blood pressure reduces risk fatal non-fatal cardiovascular events , primarily strokes myocardial infarctions . ( 1.1 ) • angina pectoris . ( 1.2 ) • heart failure , reduce risk cardiovascular mortality heart failure hospitalizations patients heart failure ( 1.3 )",
    "contraindications": "• administer daily . titrate weekly longer intervals needed tolerated . ( 2 ) • hypertension : starting dose 25 100 mg. ( 2.1 ) • angina pectoris : starting dose 100 mg. ( 2.2 ) • heart failure : starting dose 12.5 25 mg. ( 2.3 ) • switching immediate-release metoprolol metoprolol succinate extended-release tablets : total daily dose metoprolol succinate extended-release tablets . ( 2 )",
    "warningsAndPrecautions": "metoprolol succinate extended-release tablets containing metoprolol succinate equivalent indicated weight metoprolol tartrate , usp available follows : metoprolol succinate extended-release tablets usp , 50 mg white off-white , round shaped , film coated scored tablets , debossed one side score debossed 50 side . bottles 30 ndc 68788-8869-3 bottles 60 ndc 68788-8869-6 bottles 90 ndc 68788-8869-9 store 25°c ( 77°f ) ; excursions permitted 15 30°c ( 59 86°f ) [ usp controlled room temperature ] .",
    "adverseReactions": "metoprolol succinate extended-release tablets contraindicated severe bradycardia , second third degree heart block , cardiogenic shock , decompensated heart failure , sick sinus syndrome ( unless permanent pacemaker place ) , patients hypersensitive component product .",
    "indications_original": "Metoprolol succinate is a beta-adrenergic blocker indicated for the treatment of: • Hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. (1.1) • Angina Pectoris. (1.2) • Heart Failure, to reduce the risk of cardiovascular mortality and heart failure hospitalizations in patients with heart failure ( 1.3 )",
    "contraindications_original": "• Administer once daily. Titrate at weekly or longer intervals as needed and tolerated. ( 2 ) • Hypertension: Starting dose is 25 to 100 mg. ( 2.1 ) • Angina Pectoris: Starting dose is 100 mg. ( 2.2 ) • Heart Failure: Starting dose is 12.5 or 25 mg. ( 2.3 ) • Switching from immediate-release metoprolol to metoprolol succinate extended-release tablets: use the same total daily dose of metoprolol succinate extended-release tablets. ( 2 )",
    "warningsAndPrecautions_original": "Metoprolol succinate extended-release tablets containing metoprolol succinate equivalent to the indicated weight of metoprolol tartrate, USP are available as follows:\n                  \n                     Metoprolol succinate extended-release tablets USP, 50 mg\n                  \n                  White to off-white, round shaped, film coated scored tablets, debossed with I on one side of the score and debossed with 50 on the other side.\n                  Bottles of 30 NDC 68788-8869-3\n                  Bottles of 60 NDC 68788-8869-6\n                  Bottles of 90 NDC 68788-8869-9\n                  Store at 25°C (77°F); excursions permitted to 15 to 30°C (59 to 86°F) [see USP Controlled Room Temperature].",
    "adverseReactions_original": "Metoprolol succinate extended-release tablets are contraindicated in severe bradycardia, second or third degree heart block, cardiogenic shock, decompensated heart failure, sick sinus syndrome (unless a permanent pacemaker is in place), and in patients who are hypersensitive to any component of this product."
}